Terbium-161 for PSMA-Targeted Radionuclide Therapy of Prostate Cancer

被引:0
|
作者
Mueller, C. [1 ]
Umbricht, C. A. [1 ]
Gracheva, N. [1 ]
Tschan, V. J. [1 ]
Pellegrini, G. [2 ]
Bernhardt, P. [3 ]
Zeevaart, J. R. [4 ]
Koester, U. [5 ]
Schibli, R. [1 ]
van der Meulen, N. P. [1 ]
机构
[1] Paul Scherrer Inst, Villigen, Switzerland
[2] Univ Zurich, Vetsuisse Fac, Zurich, Switzerland
[3] Univ Gothenburg, Gothenburg, Sweden
[4] Necsa, Pretoria, South Africa
[5] Insitut Laue Langevin, Grenoble, France
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP-164
引用
收藏
页码:S53 / S54
页数:2
相关论文
共 50 条
  • [1] Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer
    Cristina Müller
    Christoph A. Umbricht
    Nadezda Gracheva
    Viviane J. Tschan
    Giovanni Pellegrini
    Peter Bernhardt
    Jan Rijn Zeevaart
    Ulli Köster
    Roger Schibli
    Nicholas P. van der Meulen
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 1919 - 1930
  • [2] Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer
    Muller, Cristina
    Umbricht, Christoph A.
    Gracheva, Nadezda
    Tschan, Viviane J.
    Pellegrini, Giovanni
    Bernhardt, Peter
    Zeevaart, Jan Rijn
    Koster, Ulli
    Schibli, Roger
    van der Meulen, Nicholas P.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (09) : 1919 - 1930
  • [3] The (Pre)Clinical Potential of Targeted Radionuclide Therapy with Terbium-161
    Ntihabose, Carolline
    Zink, Joke
    Tamborino, Giulia
    Nonnekens, Julie
    Konijnenberg, Mark
    de Blois, Erik
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S263 - S263
  • [4] PMPA for Nephroprotection in PSMA-Targeted Radionuclide Therapy of Prostate Cancer
    Kratochwil, Clemens
    Giesel, Frederik L.
    Leotta, Karin
    Eder, Matthias
    Hoppe-Tich, Torsten
    Youssoufian, Hagop
    Kopka, Klaus
    Babich, John W.
    Haberkorn, Uwe
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (02) : 293 - 298
  • [5] Opportunities and potential challenges of using terbium-161 for targeted radionuclide therapy in clinics
    Cristina Müller
    Nicholas P. van der Meulen
    Roger Schibli
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 3181 - 3184
  • [6] Opportunities and potential challenges of using terbium-161 for targeted radionuclide therapy in clinics
    Mueller, Cristina
    van der Meulen, Nicholas P.
    Schibli, Roger
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (11) : 3181 - 3184
  • [7] PSMA-Targeted Therapy in Prostate Cancer
    Tagawa, Scott T.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (02)
  • [8] Precision strikes: PSMA-targeted radionuclide therapy in prostate cancer - a narrative review
    Szponar, Pawel
    Petrasz, Piotr
    Brzezniakiewicz-Janus, Katarzyna
    Drewa, Tomasz
    Zorga, Piotr
    Adamowicz, Jan
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [9] PSMA-targeted radioligand therapy in prostate cancer
    Heck, M. M.
    Retz, M.
    Tauber, R.
    Knorr, K.
    Kratochwil, C.
    Eiber, M.
    [J]. UROLOGE, 2017, 56 (01): : 32 - 39
  • [10] Advances in PSMA-targeted therapy for prostate cancer
    Fujin Wang
    Zhifeng Li
    Xiaoqian Feng
    Dazhuang Yang
    Mei Lin
    [J]. Prostate Cancer and Prostatic Diseases, 2022, 25 : 11 - 26